Advertisement
OPTION trial demonstrates significantly less bleeding risk with comparable efficacy
Taking a combined surgical/electrophysiology strategy to the next level
NIH grant bolsters research to refine choice of ablation candidates and targets
The procedure is safe, but prepare for AF recurrence rates approaching 50%
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Pushing the envelope in ablation of atrial fibrillation, ventricular tachycardia
Q&A with writing group vice chair Mina Chung, MD
Advertisement
Advertisement